These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 21111937)
21. Prevention of cardioembolic stroke in patients with atrial fibrillation. Weber R; Diener HC; Weimar C Expert Rev Cardiovasc Ther; 2010 Oct; 8(10):1405-15. PubMed ID: 20936927 [TBL] [Abstract][Full Text] [Related]
22. Prevention of stroke in patients with atrial fibrillation. Med Lett Drugs Ther; 2009 Jun; 51(1313):41. PubMed ID: 19478692 [No Abstract] [Full Text] [Related]
23. Stroke prevention in atrial fibrillation patients. Marinigh R; Lip GY; Lane DA Expert Opin Pharmacother; 2010 Oct; 11(14):2331-50. PubMed ID: 20718589 [TBL] [Abstract][Full Text] [Related]
24. Antithrombotic treatment and the risk of death and stroke in patients with atrial fibrillation and a CHADS2 score=1. Gorin L; Fauchier L; Nonin E; de Labriolle A; Haguenoer K; Cosnay P; Babuty D; Charbonnier B Thromb Haemost; 2010 Apr; 103(4):833-40. PubMed ID: 20135077 [TBL] [Abstract][Full Text] [Related]
25. [Even in 60-year-old atrial fibrillation is not uncommon. Advances in long-term treatment]. Steinbeck G MMW Fortschr Med; 2006 Apr; 148(15):31. PubMed ID: 16711198 [No Abstract] [Full Text] [Related]
26. Guidelines for antithrombotic therapy in atrial fibrillation: understanding the reasons for non-adherence and moving forwards with simplifying risk stratification for stroke and bleeding. Fauchier L; Lip GY Europace; 2010 Jun; 12(6):761-3. PubMed ID: 20388635 [No Abstract] [Full Text] [Related]
27. Cilostazol may prevent cardioembolic stroke in patients undergoing antiplatelet therapy. Horie N; Kaminogo M; Izumo T; Hayashi K; Tsujino A; Nagata I Neurol Res; 2015 Jul; 37(7):619-23. PubMed ID: 25798683 [TBL] [Abstract][Full Text] [Related]
28. [Antithrombotic therapy in patients with atrial fibrillation: a comment on the European guidelines]. Said SM; Nahrendorf W; Schmidt H; Braun-Dullaeus RC Dtsch Med Wochenschr; 2011 Jun; 136(25-26):1384-5. PubMed ID: 21674428 [No Abstract] [Full Text] [Related]
29. Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation. Nieuwlaat R; Capucci A; Lip GY; Olsson SB; Prins MH; Nieman FH; López-Sendón J; Vardas PE; Aliot E; Santini M; Crijns HJ; Eur Heart J; 2006 Dec; 27(24):3018-26. PubMed ID: 16731536 [TBL] [Abstract][Full Text] [Related]
30. [Complicated priorities regarding antithrombotic treatment of atrial fibrillation. Difficult to understand priority list in the national guidelines--new studies can make them clearer]. Mooe T Lakartidningen; 2008 Sep 10-16; 105(37):2472-3. PubMed ID: 19006861 [No Abstract] [Full Text] [Related]
31. Stroke prevention in elderly patients with atrial fibrillation. Lew SJ; Lim JK Singapore Med J; 2002 Apr; 43(4):198-201. PubMed ID: 12188065 [TBL] [Abstract][Full Text] [Related]
32. Stratification with CHA2DS2-VASc score is better than CHADS2 score in reducing ischemic stroke risk in patients with atrial fibrillation. Pieri A; Lopes TO; Gabbai AA Int J Stroke; 2011 Oct; 6(5):466. PubMed ID: 21951414 [No Abstract] [Full Text] [Related]
33. Novel antithrombotic therapies for the prevention of stroke in patients with atrial fibrillation. O'Donnell M; Weitz JI Am J Manag Care; 2004 Apr; 10(3 Suppl):S72-82. PubMed ID: 15152749 [TBL] [Abstract][Full Text] [Related]
34. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study. Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184 [TBL] [Abstract][Full Text] [Related]
35. Quality of care for atrial fibrillation among patients hospitalized for heart failure. Piccini JP; Hernandez AF; Zhao X; Patel MR; Lewis WR; Peterson ED; Fonarow GC; J Am Coll Cardiol; 2009 Sep; 54(14):1280-9. PubMed ID: 19778670 [TBL] [Abstract][Full Text] [Related]
36. Atrial fibrillation and anticoagulation. Maxim R Med Health R I; 2001 Mar; 84(3):96-7. PubMed ID: 11280139 [No Abstract] [Full Text] [Related]
37. Warfarin and aspirin use in atrial fibrillation among practicing cardiologist (from the AFFECTS Registry). Kowey PR; Reiffel JA; Myerburg R; Naccarelli GV; Packer DL; Pratt CM; Reiter MJ; Waldo AL; Am J Cardiol; 2010 Apr; 105(8):1130-4. PubMed ID: 20381665 [TBL] [Abstract][Full Text] [Related]
38. [Guidelines for antithrombotic therapy in atrial fibrillation: what the Italian Hemostasis and Thrombosis Society thinks]. Prisco D Haematologica; 2001 Sep; 86(9 Suppl):12-3. PubMed ID: 11759618 [No Abstract] [Full Text] [Related]
39. New concepts and approaches to stroke prevention in the new European Society of Cardiology guidelines for the management of atrial fibrillation. Kuzniatsova N; Lip GY Expert Rev Cardiovasc Ther; 2010 Dec; 8(12):1643-7. PubMed ID: 21108546 [No Abstract] [Full Text] [Related]
40. Relation of effective anticoagulation in patients with atrial fibrillation to stroke severity and survival (from the National Acute Stroke Israeli Survey [NASIS]). Schwammenthal Y; Bornstein N; Schwammenthal E; Schwartz R; Goldbourt U; Tsabari R; Koton S; Grossman E; Tanne D Am J Cardiol; 2010 Feb; 105(3):411-6. PubMed ID: 20102959 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]